R1	Subsumes Arg1:T2 Arg2:T3	
R2	Subsumes Arg1:T4 Arg2:T5	
*	OR T2 T4
R3	AND Arg1:T1 Arg2:T2	
R4	Subsumes Arg1:T7 Arg2:T9	
R5	Has_value Arg1:T7 Arg2:T8	
*	OR T10 T11
R6	AND Arg1:T10 Arg2:T12	
R7	Has_value Arg1:T20 Arg2:T21	
R8	AND Arg1:T19 Arg2:T20	
R9	AND Arg1:T17 Arg2:T18	
R10	Has_negation Arg1:T26 Arg2:T27	
*	OR T23 T24 T25
R11	AND Arg1:T23 Arg2:T28	
R12	AND Arg1:T12 Arg2:T13	
R13	AND Arg1:T17 Arg2:T19	
T1	Condition 0 16	Overlap syndrome
T2	Condition 22 52	Primary Sclerosing Cholangitis
T3	Condition 54 57	PSC
T4	Condition 62 89	Primary Biliary Cholangitis
T5	Condition 91 94	PBC
T6	Measurement 97 112	Paris criteria,
T7	Measurement 129 158	Anti-Mitochondrial Antibodies
T8	Value 113 128	strong positive
T9	Measurement 160 163	AMA
T10	Procedure 171 183	liver biopsy
T11	Procedure 187 212	cholangiographic findings
T12	Condition 229 232	PBC
T13	Condition 236 239	PSC
T17	Condition 261 280	acute liver failure
T18	Condition 305 327	hepatic encephalopathy
T19	Condition 332 344	coagulopathy
T20	Measurement 346 349	INR
T21	Value 350 355	> 1.5
T23	Drug 381 391	prednisone
T24	Drug 392 404	prednisolone
T25	Drug 412 440	immunosuppressive medication
T26	Condition 470 490	autoimmune hepatitis
T27	Negation 459 464	other
T28	Condition 448 458	indication
T30	Condition 500 518	systemic infection
T31	Non-query-able 520 603	Other clinically significant medical conditions that could interfere with the trial
T32	Pregnancy_considerations 606 710	f female of childbearing potential: known pregnancy, or unwilling to practice anticontraceptive measures
T33	Post-eligibility 713 845	History of noncompliance with medical regimens, or patients who are considered to be potentially unreliable or unable to participate
T34	Post-eligibility 847 967	Mental instability or incompetence, such that the validity of informed consent or compliance with the trial is uncertain
